COLL Next Earnings Date Notes

— Collegium Pharmaceutical (COLL) is a specialty pharmaceutical company focused on developing & commercializing innovative medications for pain management, with a notable emphasis on products designed to address the risks of prescription opioid abuse. The company's flagship portfolio includes Xtampza ER and Nucynta ER/IR, which are extended-release opioid analgesics with abuse-deterrent properties. For investors following COLL, it's critical to monitor prescription volume trends, product sales (especially for Xtampza ER & Nucynta), gross margins, and Collegium's ability to increase market share amid industry shifts and generic competition. Payer dynamics—such as formulary access & reimbursement rates—also materially impact revenues and profitability. Investors should pay close attention on the earnings call to management's commentary about product adoption, expected milestones for pipeline candidates, and regulatory or legal developments in the pain therapeutics landscape. Adjusted EBITDA and cash flow metrics are important for gauging operational efficiency & sustainability. Ultimately, tracking Collegium's performance in defending its intellectual property, managing debt, & maintaining commercial momentum in an evolving regulatory environment will provide the clearest picture of the company's long-term prospects. The next projected earnings date for COLL is 11/5/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

COLL Next Earnings Date FAQ

On this page we presented the COLL Next Earnings Date information for Collegium Pharmaceutical along with recent past earnings dates. For Q2 of 2026, COLL reported earnings of 1.920/share, with the earnings report taking place on 8/6/2026. For Q1 of 2026, COLL reported earnings of 1.760/share, with the earnings report taking place on 5/7/2026. For Q4 of 2025, COLL reported earnings of 2.040/share, with the earnings report taking place on 2/26/2026. For Q3 of 2025, COLL reported earnings of 2.250/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, COLL reported earnings of 1.680/share, with the earnings report taking place on 8/7/2025. Based on these past earnings dates, the projected next earnings date for COLL is 11/5/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Collegium Pharmaceutical. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Collegium Pharmaceutical shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Collegium Pharmaceutical next earnings dates as well as any other stock out there in our coverage universe, to see when the next COLL earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up COLL's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the COLL next earnings date.